title: Extended progression-free survival in two patients with alveolar soft part sarcoma exposed to tivantinib.
authors.affiliation: University of Miami Miller School of Medicine, Miami, FL jgoldberg2@med.miami.edu.
authors.forename: John M
authors.initials: JM
authors.lastname: Goldberg
authors.affiliation: University of Miami Miller School of Medicine, Miami, FL.
authors.forename: Tara
authors.initials: T
authors.lastname: Gavcovich
authors.affiliation: University of Miami Miller School of Medicine, Miami, FL.
authors.forename: Gaurav
authors.initials: G
authors.lastname: Saigal
authors.affiliation: University of California, Los Angeles, Los Angeles, CA.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Goldman
authors.affiliation: University of California, Los Angeles, Los Angeles, CA.
authors.forename: Lee S
authors.initials: LS
authors.lastname: Rosen
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D002648:Child; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors / Q000378:metabolism; D011760:Pyrrolidinones / Q000008:administration & dosage*; D011804:Quinolines / Q000008:administration & dosage*; D018234:Sarcoma, Alveolar Soft Part / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology / Q000556:secondary; D013848:Thigh; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: C551661:ARQ 197; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011760:Pyrrolidinones; D011804:Quinolines; C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met